REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, and the American Lung Association are ...

REDWOOD CITY, Calif. & BARCELONA, Spain--(BUSINESS WIRE)--Please note the addition of citations at the end of the release dated Sept. 4, 2022. The updated release reads: CONVERT CLINICAL TRIAL DATA ...

Doctors sometimes recommend lung coils to help someone manage severe emphysema, especially when other treatments have been unsuccessful. Their benefits include increased lung volume, exercise capacity ...

(StatePoint) More than 11 million people in the United States are living with chronic obstructive pulmonary disease (COPD), including more than 3 million people with emphysema, a type of COPD. This ...

Please provide your email address to receive an email when new articles are posted on . “We found a stepwise greater loss of lung density with increasing exacerbation frequency, predominantly in ...

REDWOOD CITY, Calif., Nov. 30, 2020 (GLOBE NEWSWIRE) -- As part of COPD Awareness Month, Pulmonx Corporation is announcing that over 20,000 patients have been treated worldwide with their Zephyr® ...

Emphysema detected on baseline low-dose chest CT (LDCT) in the lung cancer screening cohort of more than 9,000 asymptomatic adults was associated with death from all causes, chronic obstructive ...

Spectrum Health is one of the first hospitals in Michigan to offer a novel treatment for emphysema. The treatment uses the Zephyr® Valve system, an FDA-approved minimally invasive procedure requiring ...

Researchers at Weill Cornell Medicine and New York-Presbyterian in New York have discovered that injecting mice with healthy pulmonary endothelial cells (ECs)—the cells that line the walls of blood ...